Table 1 Cardio-pulmonary bypass and pulmonary resection
From: Extracorporeal support for pulmonary resection: current indications and results
Studies | Number | Primary tumor | Lung resection | Structure involved | Morbidity | Mortality (%) | Survival |
|---|---|---|---|---|---|---|---|
Vaporciyan. 2002 [22] | 19 | Sarcoma (n = 9) Epithelial (n = 7) Others (n = 1) | PN (n = 5) Lobectomy (n = 3) | Great vessels (5 PA, 1 Ao, 5 IVC, 1 SVC) Heart (5 LA, 6 RA) | Overall 58 %: Pneumonia (37 %) Bleeding (21 %) Tracheotomy (16 %) | 11 | Curative intent (median): 64 months Palliative: 11 months |
Park. 2004 [28] | 10 | Sarcoma (n = 7) Others (n = 3) | PN (n = 2) Lobectomy (n = 3) | Great vessels (5 SVC, 1 PA, 1 Aorta) Heart (4 LA, 2 RA) | Overall 50 % Re-operation 50 % | 0 | Complete resection (median: 33.3 months) |
De Perrot. 2005 [23] | 7 | NSCLC (n = 7) | PN (n = 4) Lobectomy (n = 2) Carina (n = 1) | Great Vessels (2 SA, 1 Ao, 2 PA) Heart (2 LA) Carina 2 | Overall (58 %) ARDS (1) | 0 | 6/7 alive |
Wiebe. 2006 [24] | 13 | Sarcoma (n = 8) NSCLC (n = 3) Others (n = 2) | PN (n = 9) Lobectomy (n = 4) | Great Vessels (PA 6, PV 3, Ao 1, SVC 1) Heart (LA 9, RA 3) | ALI (n = 4) Right heart failure (n = 1) MOF (n = 1) | 15 | Sarcoma 62 % at 5-year NSCLC 33 % at 5-year |
Byrne. 2004 [25] | 14 | NSCLC (n = 7) Sarcoma (n = 5) Mesothelioma (n = 1) Thymic carcinoma (n = 1) | PN (n = 10) Lobectomy (n = 3) Wedge (n = 1) | Great vessels (PA 4, SVC 3, IVC 2 Heart (LA 3) | Low cardiac output syndrom (5/14) Re-operation for bleeding (3/14) Stroke (n = 1) Pulmonary edema (n = 1) | 0 | 21 % at 5-year |